Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases
NCT ID: NCT05476627
Last Updated: 2022-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
200 participants
OBSERVATIONAL
2022-07-01
2027-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chinese Cohort Study of Chronic Kidney Disease
NCT03041987
Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease
NCT03246191
Multi-omics Analysis of Chronic Kidney Disease
NCT05543291
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
NCT05188885
Chronic Kidney Disease Registry Platform Study
NCT06117852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hypertension Group
Biomarkers
Blood,urine and imaging biomarkers for early diagnosis and prediction of prognosis.
Diabetes Group
Biomarkers
Blood,urine and imaging biomarkers for early diagnosis and prediction of prognosis.
Hyperuricemia
Biomarkers
Blood,urine and imaging biomarkers for early diagnosis and prediction of prognosis.
Obesity
Biomarkers
Blood,urine and imaging biomarkers for early diagnosis and prediction of prognosis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biomarkers
Blood,urine and imaging biomarkers for early diagnosis and prediction of prognosis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be able to understand the process of the research;
* Volunteer for participation and be able to sign the informed consent.
Exclusion Criteria
* Patients with primary and secondary glomerular diseases
* Patients with other comorbidities that could affect the volume or the components of the kidney, such as renal cysts, polycystic kidney disease, medullary sponge kidney, hydronephrosis, renal artery stenosis, renal vein thrombosis and/or renal tumors;
* Contraindications for MRI examination;
* Pregnant or lactation patients;
* Patients with unstable vital signs, failure of other organs or dysphoria.
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Limeng Chen
director of the department of nephrology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Limeng Chen
Role: PRINCIPAL_INVESTIGATOR
Peking Union Medical College Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JS-2136
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.